Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A05847 | 33102495 | Front Med (Lausanne) | miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. | 2020 | Details |
A05848 | 33102399 | Can J Gastroenterol Hepatol | Characteristics of NAFLD Based on Hypopituitarism. | 2020 | Details |
A05849 | 33102278 | J Family Med Prim Care | Prevalence of fatty liver in metabolic syndrome. | 2020 | Details |
A05854 | 33101202 | Front Endocrinol (Lausanne) | Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. | 2020 | Details |
A05859 | 33098064 | Indian J Gastroenterol | Prevalence of elevated alanine aminotransferase levels in adult participants from a community-based study from northern part of India. | 2020 | Details |
A05862 | 33097057 | Lipids Health Dis | An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study. | 2020 | Details |
A05869 | 33095225 | Food Funct | Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet. | 2020 | Details |
A05872 | 33093663 | Nat Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. | 2020 | Details |
A05873 | 33093014 | Diabetes | ETV5 Regulates Hepatic Fatty Acid Metabolism Through PPAR Signaling Pathway. | 2020 | Details |
A05875 | 33092755 | JACC Clin Electrophysiol | Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation. | 2020 | Details |
A05876 | 33092030 | Int J Mol Sci | Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. | 2020 | Details |
A05880 | 33090351 | Obes Surg | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies. | 2020 | Details |
A05882 | 33090099 | Turk J Gastroenterol | Morphological evaluation of the effects of exercise on high-fat-diet-induced liver damage in rats. | 2020 | Details |
A05889 | 33086894 | Expert Opin Drug Discov | Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints. | 2020 | Details |
A05890 | 33086717 | J Clin Med | Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents. | 2020 | Details |
A05894 | 33084982 | Acta Diabetol | Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
A05900 | 33081272 | Life (Basel) | Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD. | 2020 | Details |
A05903 | 33080906 | Medicina (Kaunas) | Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients. | 2020 | Details |
A05907 | 33079450 | Mol Nutr Food Res | The Beneficial Effects of Apical Sodium-Dependent Bile Acid Transporter Inactivation Depend on Dietary Fat Composition. | 2020 | Details |
A05911 | 33078424 | J Food Biochem | Role of potato protein hydrolysate and exercise in preventing high-fat diet-induced hepatocyte apoptosis in senescence-accelerated mouse. | 2020 | Details |
A05914 | 33077425 | Drug Metab Dispos | Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis. | 2020 | Details |
A05919 | 33076261 | Antioxidants (Basel) | Western Diet Causes Obesity-Induced Nonalcoholic Fatty Liver Disease Development by Differentially Compromising the Autophagic Response. | 2020 | Details |
A05923 | 33075504 | Diabetes Metab | Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study. | 2020 | Details |
A05926 | 33073046 | Transl Gastroenterol Hepatol | Approach to prevention of non-alcoholic fatty liver disease after liver transplantation. | 2020 | Details |
A05932 | 33072167 | Nutr Metab (Lond) | Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme. | 2020 | Details |
A05933 | 33071981 | Front Endocrinol (Lausanne) | Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function. | 2020 | Details |
A05934 | 33071979 | Front Endocrinol (Lausanne) | Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. | 2020 | Details |
A05935 | 33071964 | Front Endocrinol (Lausanne) | Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity. | 2020 | Details |
A05937 | 33070506 | J Prev Med Public Health | Relationship Between Non-alcoholic Fatty Liver Disease and Decreased Bone Mineral Density: A Retrospective Cohort Study in Korea. | 2020 | Details |
A05938 | 33070425 | Int J Clin Pract | Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. | 2020 | Details |
A05940 | 33069975 | Comput Methods Programs Biomed | Combined methods of optical spectroscopy and artificial intelligence in the assessment of experimentally induced non-alcoholic fatty liver. | 2020 | Details |
A05944 | 33067796 | J Endocrinol Invest | Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome. | 2020 | Details |
A05946 | 33067533 | Sci Rep | HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse. | 2020 | Details |
A05947 | 33066497 | J Pers Med | Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development. | 2020 | Details |
A05950 | 33065985 | Nutrients | Genomics in Personalized Nutrition: Can You "Eat for Your Genes"? | 2020 | Details |
A05952 | 33064664 | Endocr Connect | The hepatic lipidome and HNF4α and SHBG expression in human liver. | 2020 | Details |
A05956 | 33061886 | Food Nutr Res | Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver disease. | 2020 | Details |
A05958 | 33061754 | Turk Pediatri Ars | The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity. | 2020 | Details |
A05960 | 33061293 | Drug Des Devel Ther | Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice. | 2020 | Details |
A05961 | 33060775 | Sci Rep | Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease. | 2020 | Details |
A05962 | 33060605 | Sci Rep | Clusterin overexpression protects against western diet-induced obesity and NAFLD. | 2020 | Details |
A05966 | 33059584 | BMC Gastroenterol | Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF). | 2020 | Details |
A05969 | 33058854 | Metabolism | Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women. | 2020 | Details |
A05971 | 33058486 | Pediatr Obes | A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity. | 2020 | Details |
A05972 | 33057854 | Curr Diab Rep | Tissue-Specific Fructose Metabolism in Obesity and Diabetes. | 2020 | Details |
A05973 | 33055335 | Wiad Lek | APOPTOTIC PROCESSES' RESEARCH ON THE MODEL OF TYPE 2 DIABETES MELLITUS ON OBESITY'S BACKGROUND UNDER THE INFLUENCE OF DENSE BEAN EXTRACT. | 2020 | Details |
A05974 | 33055315 | Rom J Intern Med | Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
A05976 | 33053981 | Zhonghua Gan Zang Bing Za Zhi | [Physical activity intervention for non-alcoholic fatty liver disease in children]. | 2020 | Details |
A05982 | 33052552 | Obes Surg | Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan. | 2020 | Details |
A05984 | 33051603 | Nat Rev Gastroenterol Hepatol | Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. | 2020 | Details |
A05985 | 33050862 | Curr Pharm Biotechnol | Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review. | 2022 | Details |
A05986 | 33050482 | Int J Mol Sci | Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach. | 2020 | Details |
A05987 | 33050138 | Biomedicines | Tissue-Specific Role of Macrophages in Noninfectious Inflammatory Disorders. | 2020 | Details |
A05988 | 33050067 | Biomolecules | Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH). | 2020 | Details |
A05992 | 33048844 | J Clin Invest | Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis. | 2021 | Details |
A05998 | 33045403 | Contemp Clin Trials | The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. | 2020 | Details |
A06002 | 33042004 | Front Endocrinol (Lausanne) | Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity. | 2020 | Details |
A06007 | 33038914 | Curr Pediatr Rev | Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
A06008 | 33038873 | Pediatr Res | Pediatric obesity-related non-alcoholic fatty liver disease: waist-to-height ratio best anthropometrical predictor. | 2020 | Details |
A06018 | 33037656 | Clin Endocrinol (Oxf) | Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease. | 2020 | Details |
A06020 | 33037249 | Sci Rep | Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis. | 2020 | Details |
A06022 | 33036939 | Surg Obes Relat Dis | Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. | 2020 | Details |
A06023 | 33036418 | Diagnostics (Basel) | Optimization of Point-Shear Wave Elastography by Skin-to-Liver Distance to Assess Liver Fibrosis in Patients Undergoing Bariatric Surgery. | 2020 | Details |
A06027 | 33035599 | Diabetes Res Clin Pract | Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial. | 2020 | Details |
A06032 | 33033573 | World J Hepatol | Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy. | 2020 | Details |
A06036 | 33032515 | Curr Med Imaging | Evaluation and Comparative Correlation of Abdominal Fat Related Parameters in Obese and Non-obese Groups Using Computed Tomography. | 2021 | Details |
A06039 | 33031970 | Ann Hepatol | Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. | 2020 | Details |
A06052 | 33027657 | Cell Rep | Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content. | 2020 | Details |
A06053 | 33027655 | Cell Rep | The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. | 2020 | Details |
A06058 | 33025629 | NMR Biomed | In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T. | 2020 | Details |
A06062 | 33024913 | Hepatol Commun | Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity. | 2020 | Details |
A06063 | 33024911 | Hepatol Commun | Developmental Programming of NAFLD by Parental Obesity. | 2020 | Details |
A06064 | 33024398 | World J Gastroenterol | Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant. | 2020 | Details |
A06068 | 33022287 | Food Chem Toxicol | MEHP/ethanol co-exposure favors the death of steatotic hepatocytes, possibly through CYP4A and ADH involvement. | 2020 | Details |
A06069 | 33020474 | Nat Commun | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. | 2020 | Details |
A06072 | 33017572 | Life Sci | Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. | 2020 | Details |
A06073 | 33016540 | Aliment Pharmacol Ther | Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. | 2020 | Details |
A06078 | 33014333 | Cell Biosci | Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice. | 2020 | Details |
A06079 | 33014047 | Int J Endocrinol | Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia. | 2020 | Details |
A06081 | 33013688 | Front Endocrinol (Lausanne) | Abdominal Adiposity and Total Body Fat as Predictors of Cardiometabolic Health in Children and Adolescents With Obesity. | 2020 | Details |
A06086 | 33011976 | Acta Psychiatr Scand | Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort. | 2020 | Details |
A06088 | 33011191 | Prog Lipid Res | The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. | 2020 | Details |
A06089 | 33010471 | Mol Metab | Dysregulated lipid metabolism links NAFLD to cardiovascular disease. | 2020 | Details |
A06090 | 33010412 | Clin Gastroenterol Hepatol | Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD. | 2020 | Details |
A06096 | 33009010 | AIDS | Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. | 2020 | Details |
A06097 | 33008924 | J Lipid Res | Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition. | 2020 | Details |
A06099 | 33007695 | Food Chem | Polyphenols of cambuci (Campomanesia phaea (O. Berg.)) fruit ameliorate insulin resistance and hepatic steatosis in obese mice. | 2020 | Details |
A06104 | 33006810 | Helicobacter | Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. | 2020 | Details |
A06106 | 33006125 | Adv Ther | Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data. | 2020 | Details |
A06107 | 33005474 | Liver Res | MiR-22 as a metabolic silencer and liver tumor suppressor. | 2020 | Details |
A06109 | 33004402 | BMJ Open Diabetes Res Care | Metabolic and energetic benefits of microRNA-22 inhibition. | 2020 | Details |
A06110 | 33004251 | Rev Gastroenterol Mex (Engl Ed) | Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. | 2020 | Details |
A06112 | 33002297 | Mol Nutr Food Res | Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via Modulating Fecal Metabolome in High-Fat Diet-Fed Mice. | 2020 | Details |
A06113 | 33002003 | PLoS One | REV-ERB agonism improves liver pathology in a mouse model of NASH. | 2020 | Details |
A06114 | 33001570 | Diabetes Obes Metab | Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. | 2020 | Details |
A06119 | 32998280 | Metabolites | Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism. | 2020 | Details |
A06124 | 32997875 | Mol Nutr Food Res | Characterization of the Nutritional Composition of a Biotechnologically Produced Oyster Mushroom and its Physiological Effects in Obese Zucker Rats. | 2020 | Details |
A06130 | 32994765 | Postepy Dermatol Alergol | Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications. | 2019 | Details |
A06131 | 32994276 | Diabetes | Muscular G9a Regulates Muscle-Liver-Fat Axis by Musclin Under Overnutrition in Female Mice. | 2020 | Details |
A06134 | 32993686 | J Neuroinflammation | Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease. | 2020 | Details |